TuHURA BIOSCIENCES, INC./NV Dividends, Preferred Stock, Cash
TuHURA BIOSCIENCES, INC./NV (HURA) reported Dividends, Preferred Stock, Cash of $2.09 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Dividends, Preferred Stock
us-gaap:DividendsPreferredStockCash · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, cash for the quarter ending 2026-06-30 was $2.09K, a 0.00% change year-over-year.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, cash for the quarter ending 2026-03-31 was $2.09K, a 0.00% change year-over-year.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, cash for the quarter ending 2025-12-31 was $2.09K.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, cash for the quarter ending 2025-09-30 was $2.09K, a 4.45% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, cash for fiscal 2025 was $8.36K, a 300.00% increase from fiscal 2024.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, cash for fiscal 2024 was $2.09K.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, cash for fiscal 2024 was $8.00K, a 0.00% change from fiscal 2023.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, cash for fiscal 2023 was $8.00K, a 0.00% change from fiscal 2022.
| Period end | Dividends, Preferred Stock, Cash 3 month | Dividends, Preferred Stock, Cash 6 month | Dividends, Preferred Stock, Cash 6 month as first filed | Dividends, Preferred Stock, Cash 9 month | Dividends, Preferred Stock, Cash 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.09K 10-Q · filed 2026-08-14 | $4.18K 10-Q · filed 2026-08-14 | $6.27K derived: sum of 3 quarters · filed 2026-08-14 | $8.36K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $2.09K 10-Q · filed 2026-05-15 | $4.18K derived: sum of 2 quarters · filed 2026-05-15 | $6.27K derived: sum of 3 quarters · filed 2026-05-15 | $8.36K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $2.09K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.18K derived: sum of 2 quarters · filed 2026-03-31 | $6.27K derived: sum of 3 quarters · filed 2026-08-14 | $8.36K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $2.09K 10-Q · filed 2025-11-14 | $4.18K derived: sum of 2 quarters · filed 2026-08-14 | $6.27K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | $2.09K 10-Q · filed 2026-08-14 | $4.18K 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $2.09K 10-Q · filed 2026-05-15 | ||||
| 2024-12-31 | $2.09K 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $2.00K 10-Q · filed 2024-11-14 | $4.00K derived: sum of 2 quarters · filed 2024-11-14 | $6.00K derived: sum of 3 quarters · filed 2024-11-14 | $8.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2024-06-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07 | $4.00K derived: sum of 2 quarters · filed 2024-10-07 | $6.00K derived: sum of 3 quarters · filed 2024-10-07 | $8.00K 10-K · filed 2024-10-07 | |
| 2024-03-31 | $2.00K 10-Q · filed 2024-05-14 | $4.00K derived: sum of 2 quarters · filed 2024-05-14 | $6.00K 10-Q · filed 2024-05-14 | $8.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-12-31 | $2.00K 10-Q · filed 2024-02-14 | $4.00K 10-Q · filed 2024-02-14 | $6.00K derived: sum of 3 quarters · filed 2024-11-14 | $8.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-09-30 | $2.00K 10-Q · filed 2024-11-14 | $4.00K derived: sum of 2 quarters · filed 2024-11-14 | $6.00K derived: sum of 3 quarters · filed 2024-11-14 | $8.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07 | $4.00K derived: sum of 2 quarters · filed 2024-10-07 | $6.00K derived: sum of 3 quarters · filed 2024-10-07 | $8.00K 10-K · filed 2024-10-07 | |
| 2023-03-31 | $2.00K 10-Q · filed 2024-05-14 | $4.00K derived: sum of 2 quarters · filed 2024-05-14 | $6.00K 10-Q · filed 2024-05-14 | $8.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $2.00K 10-Q · filed 2024-02-14 | $4.00K 10-Q · filed 2024-02-14 | $6.00K derived: sum of 3 quarters · filed 2024-02-14 | $8.00K derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | $2.00K 10-Q · filed 2023-11-13 | $4.00K derived: sum of 2 quarters · filed 2023-11-13 | $6.00K derived: sum of 3 quarters · filed 2023-11-13 | $8.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-18 | $4.00K derived: sum of 2 quarters · filed 2023-09-18 | $6.00K derived: sum of 3 quarters · filed 2023-09-18 | $8.00K 10-K · filed 2023-09-18 | |
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-11 | $4.00K derived: sum of 2 quarters · filed 2023-05-11 | $6.00K 10-Q · filed 2023-05-11 | $8.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $2.00K 10-Q · filed 2023-02-14 | $4.00K 10-Q · filed 2023-02-14 | $6.00K derived: sum of 3 quarters · filed 2023-02-14 | $8.00K derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-09-30 | $2.00K 10-Q · filed 2022-11-09 | $4.00K derived: sum of 2 quarters · filed 2022-11-09 | $6.00K derived: sum of 3 quarters · filed 2022-11-09 | $8.00K derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $4.00K derived: sum of 2 quarters · filed 2022-09-27 | $6.00K derived: sum of 3 quarters · filed 2022-09-27 | $8.00K 10-K · filed 2022-09-27 | |
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-13 | $4.00K derived: sum of 2 quarters · filed 2022-05-13 | $6.00K 10-Q · filed 2022-05-13 | $8.00K derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $2.00K 10-Q · filed 2022-02-11 | $4.00K 10-Q · filed 2022-02-11 | $6.00K derived: sum of 3 quarters · filed 2022-02-11 | $8.00K derived: sum of 4 quarters · filed 2022-02-11 | |
| 2020-09-30 | $2.00K 10-Q · filed 2021-11-15 | $4.00K derived: sum of 2 quarters · filed 2021-11-15 | $6.00K derived: sum of 3 quarters · filed 2021-11-15 | $8.00K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $4.00K derived: sum of 2 quarters · filed 2021-09-28 | $6.00K derived: sum of 3 quarters · filed 2021-09-28 | $8.00K 10-K · filed 2021-09-28 | |
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-13 | $4.00K derived: sum of 2 quarters · filed 2021-05-13 | $6.00K 10-Q · filed 2021-05-13 | ||
| 2019-12-31 | $2.00K 10-Q · filed 2021-02-12 | $4.00K 10-Q · filed 2021-02-12 | |||
| 2019-09-30 | $2.00K 10-Q · filed 2020-11-12 | ||||
| 2015-12-31 | $6.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | $4.18K 10-Q · filed 2016-02-12 | $2.09K derived: sum of 3 quarters · filed 2016-02-12 | -$4.18K derived: sum of 4 quarters · filed 2016-02-12 | |
| 2015-09-30 | -$2.09K 10-Q · filed 2015-11-16 | -$4.18K derived: sum of 2 quarters · filed 2015-11-16 | -$10.45K derived: sum of 3 quarters · filed 2015-11-16 | ||
| 2015-06-30 | -$2.09K derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-16 | -$8.36K derived: sum of 2 quarters · filed 2015-11-16 | -$6.27K 10-K · filed 2015-11-16 | ||
| 2015-03-31 | -$6.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | -$4.18K 10-Q · filed 2015-05-15 | |||
| 2014-12-31 | $2.09K 10-Q · filed 2016-02-12 | -$2.09K 10-Q · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |